Research, Select, & Monitor Saturday, May 30, 2020 4:38:25 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Novartis International AG$87.43$1.151.33%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Novartis International AG vs Drug Manufacturers / Major

Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.

Most of the firms here are multi-billion dollar companies that provide America and the world with a majority of the drugs they take on what is sometimes a daily basis. These companies usually have their own laboratories that design and develop new and innovative drugs for use in medicine. The research projects their own labs can not handle are typically contracted out to smaller clinical research firms who specialize in pharmaceuticals. Profit margins can be very high in this industry, which has helped fund the enormous amounts of research required to develop a new prescription drug.
 Totals Company Industry
  Sales: $48,677.0 Mil $377,179.0 Mil
  Market Cap: $200,389.6 Mil $1,708,942.0 Mil
  Analysts Recommendation: Buy Buy

 Averages Company Industry
  Historic Revenue: (8.4%) 2.8%
  Estimated Revenue: 2.1% 7.3%
  Historic Earnings: 2.9% 7.5%
  Estimated Earnings: 9.9% 9.5%
  Stock Price (1 Year): 1.9% 16.8%
  Cash per Share: (15.6%) 1.3%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 13.9 16.3
  Price-to-Sales: 4.1 N/A
  Price-to-Book: 3.6 10.9
  Dividend Yield: N/A N/A
  Market Cap: $200,389.6 Mil $189,882.4 Mil
  Net Margin: 26.4% 25.6%
  Gross Margin: 70.4% 70.9%
  Return on Equity: .2 .5
  Return on Assets: .1 .1
  Balance Sheet
  Current Ratio: 1.0 1.1
  Quick Ratio: .8 .9
  Cash Ratio: .4 .4
  Debt-to-Equity: 1.1 3.3
  Interest Coverage: .8 .3
  Relative-Strength Index: 54.3 N/A

 Other companies in Drug Manufacturers / Major Price Market Cap
  Johnson & Johnson  (JNJ) $148.75 $397,311.3 Mil
  Pfizer, Inc.  (PFE) $38.19 $212,924.9 Mil
  Merck & Co., Inc.  (MRK) $80.72 $205,593.8 Mil
  Abbott  (ABT) $94.92 $169,052.5 Mil
  AstraZeneca PLC  (AZN) $54.60 $144,366.1 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2020 All rights reserved.